Recipient of federal assistance · BLOOMINGTON, IN

MEDOSOME BIOTEC LLC

MEDOSOME BIOTEC LLC received $356.3K in federal grants and other assistance in FY2026, on 6 actions. It has no federal contracts in the loaded years. Since FY2021: $7.4M. Its largest awarding agency was National Institutes of Health ($356.3K).

Assistance · FY2026
$356.3K
New awards
1
Actions
6
Since FY2021
$7.4M
UEI
MJJJFTJE1SB5
Location
BLOOMINGTON, IN
Businesses
Open in the explorerFederal grants & assistance

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

Assistance by fiscal year

  1. 2.5MFY2021
  2. 2.8MFY2022
  3. 1.3MFY2023
  4. 350KFY2024
  5. 0FY2025
  6. 356.3KFY2026

By type

  1. Grants$356.3K100%

Top programs · Awarding agencies

Obligations in FY2026.

Top programs

  1. 93.847 · Diabetes, Digestive, and Kidney Diseases Extramural Research$356.3K100%

Awarding agencies

  1. National Institutes of Health$356.3K100%
    Department of Health and Human Services

Largest awards

  1. A METHOD FOR ACCURATE AND SENSITIVE DETECTION OF HIV DRUG-RESISTANT MINORITY VARIANTS - PROJECT SUMMARY / ABSTRACT DRUG RESISTANCE TO HIV…$2M
    93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Project grant· Jul 19, 2022 – May 19, 2026· R42AI122855
  2. NEXT GENERATION QUANTITATIVE HCV DRUG RESISTANCE ASSAY - PROJECT SUMMARY / ABSTRACT THE OBJECTIVE OF THIS PHASE II APPLICATION IS TO…$1.6M
    93.847 · Diabetes, Digestive, and Kidney Diseases Extramural Research· National Institutes of Health· Project grant· Jul 19, 2021 – Jan 6, 2026· R44DK112540
  3. DEVELOPING GLP-1 PRODUCING GENETICALLY ENGINEERED PROBIOTICS FOR TREATMENT OF METABOLIC DISEASES - PROJECT SUMMARY / ABSTRACT THE…$356.3K
    93.847 · Diabetes, Digestive, and Kidney Diseases Extramural Research· National Institutes of Health· Project grant· Jul 14, 2026 – Sep 9, 2026· R43DK146558
  4. METABOLISM AND MITOCHONDRIAL ENERGETICS THERAPY FOR SEPTIC SHOCK - PROJECT SUMMARY / ABSTRACT METABOLIC REPROGRAMMING PLAYS A CRITICAL ROLE…$350K
    93.859 · Biomedical Research and Research Training· National Institutes of Health· Project grant· Sep 12, 2024 – Feb 18, 2026· R42GM151928
  5. ENGINEERING NEXT GENERATION PROBIOTICS FOR DELIVERY OF THERAPEUTICS - PROJECT SUMMARY / ABSTRACT PEPTIDE AND PROTEIN DRUGS (PPDS) ARE…$325K
    93.350 · National Center for Advancing Translational Sciences· National Institutes of Health· Project grant· Jul 27, 2023 – Dec 12, 2025· R43TR004525

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2021–FY2026.